We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$4.45B
AUM Growth
+$175M
Cap. Flow
-$73.9M
Cap. Flow %
-1.66%
Top 10 Hldgs %
32.06%
Holding
404
New
37
Increased
55
Reduced
144
Closed
19

Top Buys

Rank Stock Value
1
CG icon
Carlyle Group
CG
+$35.2M
2
MTDR icon
Matador Resources
MTDR
+$10.3M
3
DNOW icon
DNOW Inc
DNOW
+$9.86M
4
BBBY
Bed Bath & Beyond Inc
BBBY
+$7.17M
5
APD icon
Air Products & Chemicals
APD
+$4.82M

Top Sells

Rank Stock Value
1
TPR icon
Tapestry
TPR
+$45.4M
2
SLB icon
SLB Ltd
SLB
+$13.1M
3
NOV icon
NOV
NOV
+$9.35M
4
AXS icon
AXIS Capital
AXS
+$6.1M
5
IBM icon
IBM
IBM
+$5.75M

Sector Composition

Rank Sector Weight
1 Financials 23.98%
2 Energy 16.06%
3 Healthcare 14.41%
4 Technology 11.1%
5 Industrials 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JEF icon
1
Jefferies Financial Group
JEF
$12.7B
$204M 4.57%
8,681,650
+103,134
+1% +$2.39M
ESGR
2
DELISTED
Enstar Group
ESGR
$181M 4.05%
1,197,542
-12,571
-1% -$1.73M
BAX icon
3
Baxter International
BAX
$12.8B
$160M 3.59%
4,073,312
-56,143
-1% -$2.25M
QCOM icon
4
Qualcomm
QCOM
$164B
$142M 3.2%
1,797,800
-27,616
-2% -$2.2M
DVN icon
5
Devon Energy
DVN
$51.3B
$130M 2.91%
1,632,916
-23,950
-1% -$1.74M
ABT icon
6
Abbott
ABT
$188B
$123M 2.76%
3,009,204
+5,178
+0.2% +$203K
DOV icon
7
Dover
DOV
$26.7B
$123M 2.76%
1,674,749
-61,933
-4% -$4.33M
ROP icon
8
Roper Technologies
ROP
$40.4B
$122M 2.75%
837,598
-29,862
-3% -$4.17M
BUD icon
9
AB InBev
BUD
$164B
$122M 2.74%
1,063,467
-25,665
-2% -$2.82M
BN icon
10
Brookfield
BN
$102B
$121M 2.72%
11,760,319
-280,966
-2% -$2.81M
FLR icon
11
Fluor
FLR
$6.54B
$108M 2.43%
1,408,297
-35,934
-2% -$2.74M
SLB icon
12
SLB Ltd
SLB
$72.7B
$101M 2.28%
859,797
-127,126
-13% -$13.1M
USB icon
13
US Bancorp
USB
$97.9B
$98.1M 2.2%
2,264,096
-18,107
-0.8% -$756K
IBM icon
14
IBM
IBM
$213B
$97M 2.18%
559,806
-31,949
-5% -$5.75M
NOV icon
15
NOV
NOV
$6.84B
$94.3M 2.12%
1,145,416
-125,477
-10% -$9.35M
NE
16
DELISTED
Noble Corporation
NE
$92.6M 2.08%
3,158,154
-61,032
-2% -$1.68M
RNR icon
17
RenaissanceRe
RNR
$13.8B
$91.2M 2.05%
852,182
-54,664
-6% -$5.6M
JNJ icon
18
Johnson & Johnson
JNJ
$640B
$88.6M 1.99%
846,757
-29,715
-3% -$3M
GOOG icon
19
Alphabet (Google) Class C
GOOG
$4.11T
$85.9M 1.93%
2,968,989
-78,913
-3% -$2.14M
GSAT icon
20
Globalstar
GSAT
$10.1B
$84M 1.89%
1,318,403
-12,724
-1% -$652K
MRK icon
21
Merck
MRK
$322B
$83.6M 1.88%
1,514,570
-92,902
-6% -$5.07M
LH icon
22
Labcorp
LH
$25.2B
$81M 1.82%
920,686
-14,953
-2% -$1.3M
MSFT icon
23
Microsoft
MSFT
$2.9T
$78.8M 1.77%
1,889,040
+55,250
+3% +$2.24M
MKL icon
24
Markel Group
MKL
$25.2B
$77.1M 1.73%
117,656
+455
+0.4% +$287K
BX icon
25
Blackstone
BX
$104B
$77M 1.73%
2,347,141
+87,144
+4% +$2.69M
1
2 3 4 5

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q2 2014 Portfolio in Review

As of Q2 2014, Beck Mack & Oliver held 404 positions worth $4.45B, up 4.1% from $4.28B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Beck Mack & Oliver's Q2 2014 filing shows 37 new, 55 increased, 144 reduced and 19 closed positions. Its largest new stake was Carlyle Group: 1,070,406 shares worth $36.4M. The largest sale was Tapestry, an estimated $45.4M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 24% a quarter earlier, followed by Energy and Healthcare.

  • Beck Mack & Oliver's largest Q2 2014 buy was Carlyle Group: 1,070,406 shares worth $36.4M.
  • Beck Mack & Oliver added most to Matador Resources in Q2 2014, an estimated $10.3M increase.
  • Beck Mack & Oliver's biggest Q2 2014 reduction was SLB Ltd, cutting an estimated $13.1M.
  • Beck Mack & Oliver fully exited Tapestry in Q2 2014, selling an estimated $45.4M.
  • Beck Mack & Oliver's ten largest holdings make up 32% of its $4.45B portfolio in Q2 2014.
  • Beck Mack & Oliver opened 37 new positions and closed 19 in Q2 2014.
  • Beck Mack & Oliver's portfolio value rose 4.1% quarter-over-quarter to $4.45B.

Based on Beck Mack & Oliver's 13F filing for Q2 2014, filed 31 Jul 2014.